Page last updated: 2024-10-30

leflunomide and Necrotizing Pyelonephritis

leflunomide has been researched along with Necrotizing Pyelonephritis in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alfano, G1
Fontana, F1
Guaraldi, G1
Cappelli, G1
Mussini, C1

Other Studies

1 other study available for leflunomide and Necrotizing Pyelonephritis

ArticleYear
Successful treatment of BK virus associated-nephropathy in a human immunodeficiency virus-positive kidney transplant recipient.
    International journal of STD & AIDS, 2020, Volume: 31, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; BK Virus; CD4 Lymphocy

2020